NCT00363753撤回1 期
Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- mRS at three months.
研究概览
简要总结
Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.
详细描述
Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 and older.
- •Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent.
- •Women of child-bearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period.
排除标准
- •Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel, ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents.
- •Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis.
- •Allergy to aspirin or clopidogrel.
结局指标
主要结局
mRS at three months.
次要结局
- Incidence of stroke at three months, bleeding events.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3Coronary Artery DiseaseNCT04418479Joo-Yong Hahn5,506
招募中
不适用
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE TrialIschemic Heart DiseaseNCT05320926Yonsei University3,744
尚未招募
不适用
Switch from aspirin to clopidogrel in chronic stroke patientson-cardiac strokeJPRN-UMIN000011634Tokyo Womens Medical University Hospital400
已完成
3 期
Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG StudyCoronary Artery Bypass GraftingCoronary Artery DiseaseNCT00330772Hamilton Health Sciences Corporation150
已完成
3 期
Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionSAngina UnstableAcute Coronary DiseaseNCT00335452Sanofi25,086